09.11.17
EyeGate Launches Social Media Pages to Enhance Investor and Trade Relationships
WALTHAM, Mass., Sept. 11, 2017 -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company focused on developing and commercializing products using two proprietary platform technologies...
Read more